Your session is about to expire
← Back to Search
Oxycodone/acetaminophen for Pain
Study Summary
This trial will compare the efficacy of two oral painkillers in managing acute pain in elderly patients.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have used methadone before.You have used illegal drugs for non-medical reasons in the past.You are experiencing short-term pain that has been present for less than a week and is currently ongoing.The doctor plans on sending you home with pain medication in pill form.You have had a bad reaction to any of the study drugs before.You have taken ibuprofen, acetaminophen, or opioids within the last 4 hours.You have a prior history of stomach ulcers.You have a medical condition that may impact how your body processes pain medication like opioids, acetaminophen or ibuprofen. This includes conditions like hepatitis, kidney problems, thyroid issues, Addison's or Cushing's disease.You have a long-term condition that causes frequent pain, such as sickle cell disease, fibromyalgia, or nerve damage.
- Group 1: Oxycodone/acetaminophen
- Group 2: Ibuprofen/acetaminophen
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the capacity for participants in this research project?
"Unfortunately, this clinical trial is not presently enrolling any participants. It was first advertised on July 1st 2024 and the listing has been revised as recently as September 6th 2022. If you are interested in similar studies, there are currently 342 trials actively recruiting for pain management and 121 studies seeking candidates to take Oxycodone/acetaminophen."
Are there any prior experiments involving Oxycodone/acetaminophen that can inform our research?
"Currently, 121 medical investigations into Oxycodone/acetaminophen are being conducted. Out of these studies, 34 have reached Phase 3 trials. The primary location for the research is Pittsburgh but there are also 1046 other sites participating in examinations of this drug's efficacy."
Is this trial currently in a state of recruitment?
"According to the listing on clinicaltrials.gov, this trial is not currently recruiting patients. Initially posted on July 1st 2024 and last edited September 6th 2022, it does not have any open spots at present. However, there are 463 other studies that require participants right now."
What ailment does Oxycodone/acetaminophen usually relieve?
"Oxycodone/acetaminophen has proven to be a viable remedy for catarrh, rhinorrhoea, musculoskeletal pain, and muscle spasms."
Has the FDA sanctioned Oxycodone/acetaminophen for medical use?
"There is a wealth of evidence indicating the safety profile of Oxycodone/acetaminophen, thereby warranting its score of 3."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger